Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 604-612

  Ostlie, Norma ^a   Milani, Monica ^a   Wang, Wei ^a   Okita, David ^a   Conti Fine, Bianca M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; CYTOKINE; INTERLEUKIN 4; NICOTINIC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; ELECTROMYOGRAPHY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0037221595     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.604     Document Type: Article

References (21)

1. Conti-Fine, B. M., M. Bellone, J. F. Howard, Jr., and M. P. Protti. 1997. Myasthenia Gravis: The Immunobiology of An Autoimmune Disease. Neuroscience Intelligence Unit, R. G. Landes. Austin.
2. Lindstrom, J. M. 2000. Acetylcholine receptors and myasthenia. Muscle Nerve 23:453.
3. Lindstrom, J. M., D. Shelton. and Y. Fujii. 1988. Myasthenia gravis. Adv. Immunol. 42:233.
4. Bellone, M., N. S. Ostlie, S. Lei, and B. M. Conti-Tronconi. 1991. Experimental myasthenia gravis in congenic mice: Sequence mapping and H-2 restriction of T helper epitopes on the α subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol. 21:2303.
5. + cells. J. Immunol 151:1025.
6. Shi, F., Li, H., Wang, H., Bai, X., van der Meide, P. H., Link, H. and Ljunggren, H. 1999. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells. J. Immunol. 162:5757.
7. Karachunski, P. I., N. S. Ostlie, D. K. Okita, R. Garman, and B. M. Conti-Fine. 1998. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis. J. Neuroimmunol. 93:108.
8. + epitope sequences of the acetylcholine receptor. J. Neuroimmunol. 95:73.
9. Karachunski, P. I., N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine. 2000. Absence of interferon-γ or interleukin-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J. Immunol. 164:5236.
10. Ostlie, N. S., P. I. Karachunski, W. Wang, C. Monfardini, M. Kronenberg, and B. M. Conti-Fine. 2001. Transgenic expression of IL10 in T cells facilitates development of experimental myasthenia gravis. J. Immunol. 15:4853.
11. Karachunski, P. I., N. S. Ostlie, D. K. Okita, and B. M. Conti-Fine. 1997. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J. Clin. Invest. 100:3027.
12. + T cell response to the human acetylcholine receptor a subunit in myasthenia gravis: A study with synthetic peptides. J. Immunol. 144:1276.
13. Infante, A. J., P. A. Thompson, K. A. Krolick, and K. A. Wall. 1991. Determinant selection in murine experimental autoimmune myasthenia gravis: Effect of the mutation on the T cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:2977.
14. Todd, J. A., and L. Steinman. 1993. The environment strikes back. Curr. Opin. Immunol. 5:863.
15. Oldstone, M. B. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12:1255.
16. Brocke, S., S. Hausmann, L. Steinman, and K. W. Wucherpfennig. 1998. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin. Immunol. 10:57.
17. Olson, J. K., J. L. Croxford, and S. D. Miller. 2001. Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T-cellmediated autoimmune disease. Viral Immunol. 14:227.
18. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
19. Balasa, B., C. Deng, J. Lee, P. Christadoss, and N. Sarvetnick. 1998. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 15:2856.
20. Drachman, D. B. 1994. Myasthenia gravis. N. Engl J. Med. 330:1797.
21. Wang, Z. Y., D. K. Okita, J. F. Howard, Jr., and B. M. Conti-Fine. 1998. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 50:1045.